ArticleCancer immunology, immunotherapy : CII2016

TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors.

Timothy T Spear et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.